Journal
FUTURE ONCOLOGY
Volume 14, Issue 14, Pages 1335-1338Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2018-0116
Keywords
checkpoint inhibitors; IMCgp100; immunotherapy; MEK inhibitors selumetinib; tumor infiltrating lymphocytes; uveal melanoma